Stable-State Midrange-Proadrenomedullin Level Is a Strong Predictor of Mortality in Patients With COPD

Maaike Zuur-Telgen, Marjolein G.J. Brusse-Keizer, Paul D.L.P.M. van der Valk, J. van der Palen, Huib A.M. Kerstjens, Ron M.G. Hendrix

Research output: Contribution to journalArticleAcademicpeer-review

19 Citations (Scopus)


Background: Midrange-proadrenomedullin (MR-proADM) has been shown to be elevated in patients hospitalized for an acute exacerbation of COPD (AECOPD) and in patients with community-acquired pneumonia. When measured during AECOPDs, MR-proADM has also been shown to be a predictor of mortality. We hypothesized that MR-proADM levels measured in a stable state could also predict mortality. Methods: We included 181 patients in whom we had paired plasma samples for MR-proADM determinations during a stable state and at hospitalization for an AECOPD when they also produced sputum. Time to death or censoring was compared between patients with MR-proADM above or below the median of 0.71 nmol/L. The predictive value of MR-proADM for survival was determined by calculating the C statistic. Results: Patients with COPD and MR-proADM levels > 0.71 nmol/L in the stable state had a threefold-higher risk of dying than did patients with MR-proADM levels < 0.71 nmol/L (hazard ratio, 2.98 [95% CI, 1.51-5.90]; C statistic, 0.76). The corrected OR for 1-year mortality was 8.90 (95% CI, 1.94-44.6) in patients with high MR-proADM levels measured in the stable state, compared with patients with low levels measured in the stable state. Conclusions: MR-proADM measured in the stable state appeared to be a strong predictor of mortality in patients with COPD. MR-proADM is far easier to measure than other predictors of mortality in COPD, such as BMI, airflow obstruction, dyspnea, and exercise capacity score.
Original languageEnglish
Pages (from-to)534-541
Issue number3
Publication statusPublished - 2014


  • IR-91892
  • METIS-305207


Dive into the research topics of 'Stable-State Midrange-Proadrenomedullin Level Is a Strong Predictor of Mortality in Patients With COPD'. Together they form a unique fingerprint.

Cite this